Holen Sie sich die Stockscreener-App
2.08
0.48%
0.01
Schlusskurs vom Vortag:
$2.07
Offen:
$2.07
24-Stunden-Volumen:
435.37K
Relative Volume:
2.15
Marktkapitalisierung:
$36.03M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+18.18%
1M Leistung:
-15.10%
6M Leistung:
-48.64%
1J Leistung:
-36.59%
1-Tages-Spanne:
$2.07
$2.08
1-Wochen-Bereich:
$1.76
$2.09
52-Wochen-Spanne:
$0.95
$4.74
Mural Oncology Plc Stock (MURA) Company Profile
Firmenname
Mural Oncology Plc
Sektor
Branche
Telefon
353 1 905 8020
Adresse
10 EARLSFORT TERRACE, DUBLIN 2
Vergleichen Sie MURA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MURA
Mural Oncology Plc
|
2.08 | 31.53M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Mural Oncology Plc Stock (MURA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-25 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-25 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2024-06-28 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-04-04 | Eingeleitet | Morgan Stanley | Overweight |
Mural Oncology Plc Aktie (MURA) Neueste Nachrichten
Xoma, a drug royalty specialist, buys another ‘zombie’ biotech - BioPharma Dive
MURA’s Unexpected Surge: Analyzing Stock Movement - StocksToTrade
Mural Oncology to be Acquired by XRA 5 - citybiz
XOMA Royalty Corporation entered into a definitive agreement to acquire Mural Oncology plc for $35.3 million. - MarketScreener
Mural Oncology To Be Acquired By XOMA Royalty - MSN
Mural Oncology plc enters acquisition agreement with XRA 5 Corp (XOMA Royalty Corporation) - Arthur Cox LLP
After culling 90% of staff, Waltham biotech finds buyer - NBC Boston
MURA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Mural Oncology plc Is Fair to Shareholders - MarketScreener
Form 8.3Mural Oncology plc - Business Wire
Citadel Group discloses 1.44% stake in Mural Oncology - Investing.com
Mural Jumps on Partnership with XOMA - Baystreet.ca
XOMA Royalty To Acquire Mural Oncology - Nasdaq
Mural Oncology to be acquired by XRA 5 Corp. for $2.035-$2.24 per share in cash - TipRanks
Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share - The Manila Times
XOMA Royalty Unit to Acquire Mural Oncology - MarketScreener
XOMA Royalty to acquire Mural Oncology for up to $2.24 per share - Investing.com
Mural Oncology Announces Entry into Agreement to be - GlobeNewswire
WALTHAM, DUBLIN, EMERYVILLEMural Oncology agrees to acquisition by XOMA Royalty subsidiary - Investing.com
98% Premium: XOMA Royalty Acquires Cancer Drug Developer Mural Oncology in $36.2M Strategic Deal - Stock Titan
Mural Oncology plc Enters Reversal Setup in Weekly ChartsQuarterly Performance Summary & Community Supported Trade Ideas - newsyoung.net
Risk adjusted return profile for Mural Oncology plc analyzedWeekly Risk Summary & Weekly Watchlist for Hot Stocks - Newser
Candlestick signals on Mural Oncology plc stock today2025 Macro Impact & Daily Entry Point Trade Alerts - Newser
Tick level data insight on Mural Oncology plc volatilityShort Setup & Smart Swing Trading Alerts - Newser
Understanding Mural Oncology plc’s price movementJuly 2025 Action & Fast Entry and Exit Trade Plans - Newser
Using flow based indicators on Mural Oncology plcInsider Buying & Safe Capital Investment Plans - Newser
Citadel Group discloses 1.53% stake in Mural Oncology - Investing.com India
Mass. biotech company cuts 90% of workforce - MSN
Citadel Group discloses 1.53% stake in Mural Oncology By Investing.com - Investing.com South Africa
Visual analytics tools that track Mural Oncology plc performanceTreasury Yields & Fast Exit and Entry Trade Guides - Newser
Multi factor analysis applied to Mural Oncology plcWeekly Profit Summary & Free Weekly Chart Analysis and Trade Guides - Newser
Smart tools for monitoring Mural Oncology plc’s price action2025 Trading Volume Trends & Real-Time Volume Spike Alerts - Newser
Is Mural Oncology plc meeting your algorithmic filter criteriaPortfolio Growth Summary & Technical Buy Zone Confirmation - Newser
What technical models suggest about Mural Oncology plc’s comebackInflation Watch & Community Shared Stock Ideas - Newser
Will breakout in Mural Oncology plc lead to full recoveryM&A Rumor & Technical Entry and Exit Alerts - Newser
Will Mural Oncology plc be affected by tariffsQuarterly Performance Summary & Free Safe Capital Growth Stock Tips - sisa-n.com
Can you recover from losses in Mural Oncology plcJuly 2025 Opening Moves & Intraday High Probability Alerts - Newser
Sentiment analysis tools applied to Mural Oncology plcJuly 2025 Outlook & Intraday High Probability Setup Alerts - Newser
Chart based analysis of Mural Oncology plc trendsTrade Risk Summary & Weekly High Return Stock Opportunities - Newser
Citadel Group discloses 1.58% stake in Mural Oncology By Investing.com - Investing.com Canada
Citadel Group discloses 1.58% stake in Mural Oncology - Investing.com
Will Mural Oncology plc Stock Benefit from AI and Green Energy Trends2025 Technical Patterns & Free Community Consensus Stock Picks - Newser
AI Tools Suggest Mural Oncology plc May Outperform This WeekVolume Spike & AI Powered Trade Plan Recommendations - beatles.ru
Mural Oncology shares rise 5.59% premarket after Vanguard Group, Inc. disclosed a position in the company. - AInvest
Sector ETF Data Correlates with Strength in Mural Oncology plcJuly 2025 Highlights & Proven Capital Preservation Methods - beatles.ru
Is Mural Oncology plc a strong candidate for buy and hold2025 Volatility Report & Verified Momentum Stock Ideas - classian.co.kr
Mural Oncology shares rise 1.81% premarket after Vanguard Group, Inc. disclosed a position in the company. - AInvest
Citadel Group discloses 1.17% stake in Mural Oncology By Investing.com - Investing.com India
Is Mural Oncology plc Stock Overbought or Oversold RSI Indicator AnalysisHigh Probability Trade Plan with Indicators - Newser
Finanzdaten der Mural Oncology Plc-Aktie (MURA)
Es liegen keine Finanzdaten für Mural Oncology Plc (MURA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Mural Oncology Plc-Aktie (MURA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Keson-Brookes Maiken | See Remarks |
Jul 18 '25 |
Sale |
2.48 |
2,158 |
5,352 |
71,406 |
0.94%
1.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):